How do you choose the appropriate first line treatment between everolimus, somatostatin analogues, or cytotoxic chemotherapy in patients with good ECOG PS and widely metastatic atypical carcinoid of the lung?

Topics: Thoracic Malignancies • Medical Oncology

Answer from: Medical Oncologist at Academic Institution

If the patient is not symptomatic from tumor burden, can start with somatostatin analogues and then add everolimus on progression. Cytotoxic chemotherapy for patients who have progressed on everolimus.

Comments

Medical Oncologist at Sanford Medical Center
What would you do for a symptomatic patient? Would...

Medical Oncologist at University of Utah
I am wondering the same thing, cap/tem or carbo/et...

Related Questions